Myomo MYO
Myomo reports record revenue of $12.3 million for Q3 2026
Myomo (MYO) filed an 8-K with the SEC on Nov 9, 2026, 4:10 pm ET. Source: the filing on SEC EDGAR.
Item 2.02 Reports results
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001193125-26-453593
- Revenue increased 22% year over year to $12.3 million
- 54% of revenue came from recurring patient sources
- Adjusted EBITDA was breakeven for the quarter
- Full-year revenue guidance narrowed to $46-47 million
Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.
